Literature DB >> 29243874

Emotional and behavioral problems in children and adolescents with neurofibromatosis type 1.

André B Rietman1,2, Thijs van der Vaart1,3,4, Ellen Plasschaert5, Bethany A Nicholson1, Rianne Oostenbrink1,3, Lianne C Krab1, Mie-Jef Descheemaeker5, Marie-Claire Y de Wit1,6, Henriëtte A Moll1,3, Eric Legius5, Pieter F A de Nijs1,2.   

Abstract

To assess emotional and behavioral problems in children and adolescents with neurofibromatosis type 1,parents of 183 individuals aged 10.8 ± 3.1 years (range 6-17) completed the Child Behavior Checklist (CBCL). Also, 173 teachers completed the Teacher's Report Form (TRF), and 88 adolescents (children from 11 to 17 years) completed the Youth Self-Report (YSR). According to parental ratings, 32% scored in the clinical range (above the 90th percentile). This percentage was much lower when rated by teachers or adolescents themselves. Scores from all informants on scales for Somatic complaints, Social problems, and Attention problems were significantly different from normative scores. Attentional problems were associated with lower verbal IQ, male gender, younger age, and ADHD-symptoms. Disease-related factors did not predict behavioral problems scores. Substantial emotional and behavioral problems were reported by parents, teachers, and to a lesser extent by adolescents with NF1 themselves. Possibly, a positive illusory bias affects the observation of behavioral problems by adolescents with NF1.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  emotional and behavioral problems; neurofibromatosis type 1; parent and teacher report; positive illusory bia; self-report

Mesh:

Year:  2017        PMID: 29243874     DOI: 10.1002/ajmg.b.32612

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  5 in total

1.  Steady-state visual evoked potentials in children with neurofibromatosis type 1: associations with behavioral rating scales and impact of psychostimulant medication.

Authors:  Eve Lalancette; Audrey-Rose Charlebois-Poirier; Kristian Agbogba; Inga Sophia Knoth; Emily J H Jones; Luke Mason; Sébastien Perreault; Sarah Lippé
Journal:  J Neurodev Disord       Date:  2022-07-22       Impact factor: 4.074

2.  Cognitive and behavioral functioning in two neurogenetic disorders; how different are these aspects in Duchenne muscular dystrophy and Neurofibromatosis type 1?

Authors:  Danique M J Hellebrekers; Sandra A M van Abeelen; Coriene E Catsman; Sander M J van Kuijk; Annick M Laridon; Sylvia Klinkenberg; Jos G M Hendriksen; Johan S H Vles
Journal:  PLoS One       Date:  2022-10-10       Impact factor: 3.752

3.  The effects of self-efficacy and social support on behavior problems in 8~18 years old children with malignant tumors.

Authors:  Qian Liu; Lin Mo; Xianqiao Huang; Lu Yu; Yang Liu
Journal:  PLoS One       Date:  2020-07-31       Impact factor: 3.240

4.  The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1.

Authors:  Francesca Cervi; Veronica Saletti; Katherine Turner; Angela Peron; Sara Bulgheroni; Matilde Taddei; Francesca La Briola; Maria Paola Canevini; Aglaia Vignoli
Journal:  Orphanet J Rare Dis       Date:  2020-09-07       Impact factor: 4.123

5.  Brain Tumors in NF1 Children: Influence on Neurocognitive and Behavioral Outcome.

Authors:  Matilde Taddei; Alessandra Erbetta; Silvia Esposito; Veronica Saletti; Sara Bulgheroni; Daria Riva
Journal:  Cancers (Basel)       Date:  2019-11-11       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.